drug
KN-01
Phase 1updated 3mo agoby PendreaBio Inc
Phase 1community read0 votes
indications
indications
Breast Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying KN-01
- phase2Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
- phase2A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
- phase2Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
- phase2Phase 2 Study of DKN-01 in Colorectal Cancer
- —Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
- phase1Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
- phase1A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab
- phase1A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that